ANAPC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.940000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.378000E-01
Normal-vs-Stage2
5.624200E-01
Normal-vs-Stage3
2.664800E-01
Normal-vs-Stage4
8.044000E-01
Stage1-vs-Stage2
7.993400E-01
Stage1-vs-Stage3
7.030300E-02
Stage1-vs-Stage4
2.147400E-01
Stage2-vs-Stage3
6.781600E-02
Stage2-vs-Stage4
2.702800E-01
Stage3-vs-Stage4
1.456070E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.100000E-01
Normal-vs-AfricanAmerican
9.303600E-01
Normal-vs-Asian
2.500200E-01
Caucasian-vs-AfricanAmerican
4.471400E-01
Caucasian-vs-Asian
1.785230E-01
AfricanAmerican-vs-Asian
1.410150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.183200E-01
Normal-vs-Female
4.920000E-01
Male-vs-Female
7.924800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.900600E-01
Normal-vs-Age(41-60Yrs)
7.761200E-01
Normal-vs-Age(61-80Yrs)
3.881000E-01
Normal-vs-Age(81-100Yrs)
4.994200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.029400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.861000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.656400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.524200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.414400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.413600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.188800E-01
Normal-vs-Daily Drinker
3.603600E-01
Normal-vs-Weekly Drinker
6.164400E-01
Normal-vs-Occasional Drinker
8.628000E-01
Normal-vs-Social Drinker
8.016600E-01
Non Drinker-vs-Daily Drinker
9.600000E-01
Non Drinker-vs-Weekly Drinker
4.790200E-01
Non Drinker-vs-Occasional Drinker
1.064230E-01
Non Drinker-vs-Social Drinker
2.166400E-01
Daily Drinker-vs-Weekly Drinker
5.033200E-01
Daily Drinker-vs-Occasional Drinker
1.388390E-01
Daily Drinker-vs-Social Drinker
2.556000E-01
Weekly Drinker-vs-Occasional Drinker
5.092000E-01
Weekly Drinker-vs-Social Drinker
6.774200E-01
Occasional Drinker-vs-Social Drinker
8.449400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.355200E-01
Normal-vs-Grade 2
2.152600E-01
Normal-vs-Grade 3
1.464640E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.069600E-02
Grade 1-vs-Grade 3
4.816900E-03
Grade 1-vs-Grade 4
5.355200E-01
Grade 2-vs-Grade 3
2.106600E-01
Grade 2-vs-Grade 4
2.152600E-01
Grade 3-vs-Grade 4
1.464640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.783200E-01
Normal-vs-NonDiabetic
4.290000E-01
Diabetic-vs-NonDiabetic
7.625200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.064600E-01
Normal-vs-NoPancreatitis
4.446200E-01
Pancreatitis-vs-NoPancreatitis
9.209800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.519800E-01
Normal-vs-N1
5.521400E-01
N0-vs-N1
6.586400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.845000E-01
Normal-vs-TP53-NonMutant
6.259600E-01
TP53-Mutant-vs-TP53-NonMutant
9.642400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
